Trial Condition(s):

Vaginal yeast infections

Activity and tolerability of BAY b 5097 500mg vaginal tablets in single dose or one day treatment of vaginal Candida infections

Bayer Identifier:

Trial_0473

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below

Inclusion Criteria

No Inclusion Criteria Available

Exclusion Criteria

No Exclusion Criteria Available

Trial Summary

Enrollment Goal

Trial Dates

December1980

August1981

Phase

N/A

Could I receive a placebo?

Products

Mycelex (Clotrimazole, BAYB5097)

Accepts Healthy Volunteers

N/A

Where to Participate

Locations

Status

Locations	Status

Vaginal yeast infections

Bayer Identifier:

ClinicalTrials.gov Identifier:

EudraCT Number:

EU CT Number:

Trial Purpose

Key Participation Requirements

sex

age

13 Years

62 Years

Inclusion Criteria

Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Trial Summary

Enrollment Goal

Trial Dates

Phase

Could I receive a placebo?

Products

Accepts Healthy Volunteers

Where to Participate

For details, please refer to trial results

Additional Information